Read the Latest ISN Journal Editorial Selectionsjbrown
Due to recent advances in understanding the molecular and cellular mechanisms underlying podocyte injury, there is potential for repurposing already approved therapeutics for treating these disorders.
This mini-review explores the complexities of repurposing drugs for kidney treatment, emphasizing the importance of extensive testing, emerging technologies, early intervention, and potential combination therapies to enhance patient outcomes.
Kidney International Reports®
The ISN Emerging Leaders Program (ELP) has fostered a network of professionals committed to self-development and change that actively contributes to multiple ISN initiatives and research projects to help advance global kidney health.
Here, the first ELP cohort presents a collective account of the program’s activities and the skills and lessons learned from participating.